PMC3295620_01
Levels of liver enzymes during treatment with tocilizumab.
CRIM2012-212381.001.jpg
PMC3295620_01_CRIM2012-212381.001.jpg
fig1
The course of AST, ALT, and GGT was shown in Figure 1. The evaluation of activity of rheumatoid arthritis with SDAI during the treatment with tocilizumab was illustrated in Figure 2.
Rheumatoid arthritis activity (SDAI) during treatment with tocilizumab.
CRIM2012-212381.002.jpg
PMC3295620_01_CRIM2012-212381.002.jpg
fig2
The course of AST, ALT, and GGT was shown in Figure 1. The evaluation of activity of rheumatoid arthritis with SDAI during the treatment with tocilizumab was illustrated in Figure 2.